{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:37:02Z","timestamp":1794569822460,"version":"4.9.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1093\/rheumatology\/kep148","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T01:43:15Z","timestamp":1245289395000},"page":"978-986","source":"Crossref","is-referenced-by-count":101,"title":["Biologic therapy in primary systemic vasculitis of the young"],"prefix":"10.1093","volume":"48","author":[{"given":"Despina","family":"Eleftheriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Dolezalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,6,17]]},"reference":[{"key":"key\n\t\t\t\t20170522175338_B1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11926-000-0041-7","article-title":"Vasculitis from the pediatric perspective","volume":"2","author":"Brogan","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"key\n\t\t\t\t20170522175338_B2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpeds.2004.06.046","article-title":"Juvenile polyarteritis: results of a multicenter survey of 110 children","volume":"145","author":"Ozen","year":"2004","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170522175338_B3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.22774","article-title":"Clinical features and outcome of pediatric Wegener's granulomatosis","volume":"57","author":"Akikusa","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00431-005-0070-3","article-title":"Vasculitis treatment \u2013 new therapeutic approaches","volume":"165","author":"Dillon","year":"2006","journal-title":"Eur J Pediatr"},{"key":"key\n\t\t\t\t20170522175338_B5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11926-007-0052-8","article-title":"Small-vessel vasculitis: therapeutic management","volume":"9","author":"Langford","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"key\n\t\t\t\t20170522175338_B6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00431-006-0212-2","article-title":"Childhood vasculitis and plasma exchange","volume":"166","author":"Wright","year":"2007","journal-title":"Eur J Pediatr"},{"key":"key\n\t\t\t\t20170522175338_B7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/adc.83.3.259","article-title":"The use of immunosuppressive and cytotoxic drugs in non-malignant disease","volume":"83","author":"Brogan","year":"2000","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t20170522175338_B8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.berh.2004.11.004","article-title":"How to induce remission in primary systemic vasculitis","volume":"19","author":"Jayne","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key\n\t\t\t\t20170522175338_B9","first-page":"C50","article-title":"Novel therapeutic approaches in vasculitis treatment","volume":"19","author":"Jayne","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170522175338_B10","first-page":"1299","article-title":"Outcome and prognostic factors during the course of primary small-vessel vasculitides","volume":"33","author":"Pavone","year":"2006","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522175338_B11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9343(03)00077-9","article-title":"Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse","volume":"114","author":"Langford","year":"2003","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170522175338_B12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/ndt\/13.7.1713","article-title":"Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis","volume":"13","author":"Haubitz","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170522175338_B13","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B14","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/art.21351","article-title":"B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus","volume":"52","author":"Marks","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.rhu.0000173225.41933.83","article-title":"Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade","volume":"11","author":"Feinstein","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"key\n\t\t\t\t20170522175338_B16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/rheumatology\/kel172","article-title":"Infliximab as rescue therapy in three cases of paediatric Wegener's granulomatosis","volume":"45","author":"Wilkinson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522175338_B17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpeds.2006.10.067","article-title":"Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases","volume":"150","author":"El-Hallak","year":"2007","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170522175338_B18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis","volume":"33","author":"Fries","year":"1990","journal-title":"Summary. Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2005.046300","article-title":"EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides","volume":"65","author":"Ozen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522175338_B21","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t20170522175338_B22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522175338_B23","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"de","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"Wegener's Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522175338_B25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.20199","article-title":"Endothelial and platelet microparticles in vasculitis of the young","volume":"50","author":"Brogan","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522175338_B27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/rheumatology\/ken373","article-title":"Diagnostic role of endothelial microparticles in vasculitis","volume":"47","author":"Erdbruegger","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522175338_B28","first-page":"86","article-title":"Circulating endothelial cells and endothelial progenitor cells in primary systemic vasculitis","volume":"25","author":"Clarke","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t20170522175338_B29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170522175338_B30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522175338_B31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","article-title":"Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis","volume":"41","author":"Lamprecht","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522175338_B32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","article-title":"Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation","volume":"109","author":"Booth","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170522175338_B33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome","volume":"146","author":"Burns","year":"2005","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170522175338_B34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","article-title":"Adalimumab: a new modality for Behcet's disease?","volume":"66","author":"van Laar","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522175338_B35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","article-title":"Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab","volume":"257","author":"Eriksson","year":"2005","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20170522175338_B36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","article-title":"Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations","volume":"6","author":"Aries","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522175338_B37","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment","volume":"54","author":"Smith","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B38","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","article-title":"Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab","volume":"45","author":"Stasi","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522175338_B39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170522175338_B40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522175338_B41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/02813430510015269","article-title":"Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response","volume":"34","author":"Omdal","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"key\n\t\t\t\t20170522175338_B42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1546-0096-7-3","article-title":"Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report","volume":"7","author":"Brogan","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"key\n\t\t\t\t20170522175338_B43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.rhu.0000173225.41933.83","article-title":"Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade","volume":"11","author":"Feinstein","year":"2005","journal-title":"J Clin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/48\/8\/978\/17386453\/kep148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:06:39Z","timestamp":1739167599000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/kep148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,17]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,6,17]]},"published-print":{"date-parts":[[2009,8]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kep148","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6,17]]}}}